𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose mitomycin C: activity in hepatocellular carcinoma

✍ Scribed by Arkom Cheirsilpa; Suthee Leelasethakul; Vorachart Auethaveekiat; Savitree Maoleekulpriroj; Nalinphan Kangsumrit; Pimpa Thanakaravit; Pisit Phanthumjida


Publisher
Springer
Year
1989
Tongue
English
Weight
370 KB
Volume
24
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical pharmacokinetics of high-dose m
✍ Rudolf B. Schilcher; John D. Young; Voravit Ratanatharathorn; Chatchada Karanes; πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 487 KB

The pharmacokinetic profile of high-dose mitomycin C was determined in blood plasma and urine of twelve patients with advanced malignancies in a program including autologous bone marrow transplantation. A total dose of 60 mg/m2 was given, either as a single 60-min infusion or divided into infusions

Reduced C-terminal Src kinase (Csk) acti
✍ Tsutomu Masaki; Masato Okada; Masaki Tokuda; Yasushi Shiratori; Osamu Hatase; Mu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 286 KB

The proto-oncogene product pp60(c-src) is the cellular homologue of the Rous sarcoma transforming gene, and it is a non-receptor-linked and membrane-associated tyrosine kinase. There is a close correlation between elevated pp60(c-src) activity and cell transformation. We have recently reported that

Mitomycin C in large infrequent doses in
✍ Wise, Gregory R. ;Kuhn, Irvin N. ;Godfrey, Thomas E. πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 415 KB

## Abstract Seventy‐one women with far‐advanced breast cancer resistant to standard chemotherapeutic agents were administered mitomycin C using an intermittent high dose schedule. One group consisted of 54 patients with measurable metastatic tumor; a second group consisted of 18 patients with nonme